Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
NeuPath Health Inc
XTSX:NPTH
NeuPath Health Inc
XTSX:NPTH
Price:
0.56
CAD
3.7%
Market Cap:
CA$31.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
NeuPath Health Inc
XTSX:NPTH
|
CA |
|
Iida Group Holdings Co Ltd
F:IIO
|
JP |
|
E
|
Exail Technologies SA
LSE:0OHC
|
FR |
|
Puradelta Lestari Tbk PT
OTC:PTPLF
|
ID |
|
Alexandria Group Oyj
F:3ZL
|
FI |
|
T
|
TDK Corp
F:TDK
|
JP |
|
M
|
Mclaren Resources Inc
F:3ML
|
CA |
|
N
|
Naturgy Energy Group SA
DUS:GAN
|
ES |
|
Earthwise Minerals Corp
F:966
|
CA |
|
B
|
Boosh Plant Based Brands Inc
F:77I
|
CA |
|
P
|
PC Gold Ltd
ASX:PC2
|
AU |
|
Italian Wine Brands SpA
F:MR3
|
IT |
|
Thomson Medical Group Ltd
F:3H5
|
SG |
|
BEC World PCL
OTC:BECVY
|
TH |
|
M
|
Mandarin Hotel PCL
SET:MANRIN
|
TH |
|
Newlox Gold Ventures Corp
F:NGO
|
CA |
|
A
|
Amarin Corporations PCL
SET:AMARIN
|
TH |
|
InfuSystem Holdings Inc
F:1TZ
|
US |
|
I
|
IRSA Inversiones y Representaciones SA
BCBA:IRSA
|
AR |
|
Asseco Business Solutions SA
F:9QQ
|
PL |
|
Strategic Investments A/S
CSE:STRINV
|
DK |
|
Savencia SA
PAR:SAVE
|
FR |
|
E
|
East Africa Metals Inc
SWB:EA1
|
CA |
|
I
|
Iida Group Holdings Co Ltd
SWB:IIO
|
JP |
Wall St Price Targets
NPTH Price Forecast
Based on 3 analysts
Based on 3 analysts
+48% Upside
from
CA$0.56
today
NeuPath Health Inc (NPTH)’s 12-month stock price forecast through October 2027 has a consensus target of CA$0.83, implying 48% upside. The forecast is based on price targets from 3 Wall Street analysts.
NPTH Analyst Rating
No ratings yet
No ratings yet
NeuPath Health Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NPTH's stock price target?
Price Target
0.83
CAD
0.83
CAD
According to Wall Street analysts, the average 1-year price target for NPTH is 0.83 CAD with a low forecast of 0.69 CAD and a high forecast of 1 CAD.
What is the Revenue forecast for NeuPath Health Inc?
Projected CAGR
9%
9%
Over the last 7 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 2 years is 9%.
What is the Gross Profit forecast for NeuPath Health Inc?
Projected CAGR
12%
12%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 2 years is 12%.